Data / Form D filings / Zosano Pharma Inc
Zosano Pharma Inc: Form D filings
Zosano Pharma Inc, a pharmaceuticals company in Fremont, CA, filed 4 Form D notices with the SEC between 2010 and 2011. The latest, on September 23, 2011, reports $4.7 million sold of a $4.7 million offering to 1 investor.
Find out what Zosano Pharma Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 34790 Ardentech Court, Fremont, CA, 94555
- Phone
- (510) 745-1200
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1418028
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2011 | Amendment | $4,705,630 | $4,705,630 | $0 | 1 | Apr 29, 2011 | sec.gov |
| Jun 6, 2011 | New notice | $4,092,810 | $4,092,810 | $0 | 1 | Apr 29, 2011 | sec.gov |
| Aug 18, 2010 | New notice | $16,000,800 | $3,111,261 | $12,889,539 | 3 | Aug 13, 2010 | sec.gov |
| Mar 30, 2010 | New notice | $39,009,000 | $39,009,000 | $0 | 6 | Jun 18, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vikram Y. Lamba | Executive Officer | |
| Jee Y. Shin | Director | |
| Greg Y. Yedinak | Executive Officer | |
| M. James Barrett, Ph.D. | Director | |
| Gail Schulze | Executive Officer, Director | |
| Thorsten Y. von Stein, M.D., Ph.D. | Executive Officer | |
| Kim James Gaumer | Executive Officer | |
| Peter James Daddona, Ph.D. | Executive Officer | |
| Michael P. Schlamp, Ph.D. | Executive Officer | |
| John P. Richard | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 19, 2011 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Zosano Pharma Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.